Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.800
-0.030 (-1.64%)
Apr 20, 2026, 3:24 PM EDT - Market open
Inhibikase Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts that cover Inhibikase Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $5.00, which forecasts a 177.78% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $8.00.
Price Target: $5.00 (+177.78%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2026.
Analyst Ratings
The average analyst rating for Inhibikase Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 4 | 4 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +122.22% | Mar 4, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +233.33% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +344.44% | Dec 26, 2025 |
| Freedom Broker | Freedom Broker | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +66.67% | Dec 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $4 | Buy | Initiates | $4 | +122.22% | Dec 11, 2025 |
Financial Forecast
Revenue This Year
252.50K
Revenue Next Year
252.50K
from 252.50K
EPS This Year
-0.50
from -0.49
EPS Next Year
-0.56
from -0.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1M | 2.1M | |
| Avg | 252,500 | 252,500 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 731.7% | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.18 | -0.34 | |
| Avg | -0.50 | -0.56 | |
| Low | -0.98 | -0.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.